FDA
approval
· 2021-02-09
FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approves a supplemental application for buspirone hydrochloride from Mylan Pharmaceuticals Inc. This is an ANDA-related approval for a generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)